STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
TAK
(TAK)
TAK
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Takeda Pharmaceutical Company Limited
(TAK)
$16.61
▼
-0.02 (-0.12%)
Chart
Share
Post on X
TAK
Takeda Pharmaceutical Company Limited
(TAK)
NYSE
$16.61
▼
-0.02 (-0.12%)
Chart Studio
Share
TAK
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
As of
2026
• vs 2025
Annual
Quarterly
Core Metrics
Market Cap
$8.92T
+28.0%
P/E Ratio
46.52
-27.9%
P/S Ratio
1.98
+30.2%
ROE
2.47%
+58.5%
ROIC
2.95%
-6.1%
FCF Yield
8.55%
-21.8%
Debt/Equity
0.63
-14.4%
Current Ratio
1.27
+26.5%
Interest Coverage
1.51x
-55.0%
Per Share
Revenue/Share
$2,860.66
-1.4%
Net Income/Share
$121.75
+78.1%
Operating CF/Share
$595.98
-2.2%
Free CF/Share
$484.24
+0.4%
Cash/Share
$377.80
+54.9%
Book Value/Share
$4,936.19
+12.4%
Tangible Book/Share
$-922.86
+27.9%
Equity/Share
$4,935.42
+12.4%
Interest Debt/Share
$3,326.48
-0.4%
Valuation
Market Cap
$8.92T
+28.0%
Enterprise Value
$13.21T
+11.7%
P/E Ratio
46.52
-27.9%
P/S Ratio
1.98
+30.2%
P/OCF Ratio
9.50
+31.3%
P/FCF Ratio
11.70
+27.9%
P/B Ratio
1.15
+14.2%
P/TB Ratio
1.15
+14.2%
EV/Sales
2.93
+13.6%
EV/EBITDA
10.47
-0.2%
Profitability
Earnings Yield
2.15%
+38.8%
FCF Yield
8.55%
-21.8%
ROE
2.47%
+58.5%
ROIC
2.95%
-6.1%
Return on Tangible Assets
3.08%
+51.1%
Capital Allocation
CapEx/OCF
18.75%
-10.1%
CapEx/Revenue
3.91%
-10.9%
CapEx/Depreciation
0.24
-7.5%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.63
-14.4%
Debt/Assets
0.32
-11.5%
Net Debt/EBITDA
3.40
-21.1%
Current Ratio
1.27
+26.5%
Interest Coverage
1.51x
-55.0%
Income Quality
4.90
-45.1%
Efficiency
Days Sales Outstanding
71 days
+22.9%
Days Payables Outstanding
81 days
+53.6%
Days Inventory
231 days
+10.6%
Receivables Turnover
5.14x
-18.6%
Payables Turnover
4.49x
-34.9%
Inventory Turnover
1.58x
-9.6%
Special Valuations
Graham Number
$3,676.93
+41.5%
Graham Net-Net
$-3,636.48
+0.6%